DEF 14AThe Ballot
Kalaris Therapeutics, Inc. files DEF 14A
Filed Dec 6, 2024 · 1y ago · Accession 0001193125-24-271972
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- DEF 14A
- Filing date
- Dec 6, 2024
- Report date
- Jan 9, 2025
- Document
- d902309ddef14a.htm
- Size
- 692 KB